AGO2 and cancer: In breast cancer, lncRNA cancer susceptibility candidate 7 (CASC7) upregulated levels of tumor necrosis factor ligand superfamily member 6 (FASLG) by targeting miR-21-5p to inhibit proliferation, invasion, and migration of cancer cells [51].